AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
RITUXIMAB in Kenya
5 products registered with PPB — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MABTHERA 100 Concentrate For Solution For Infusion | 16543/R1 | F. HOFFMAN-LA ROCHE LTD | active | 18 May 2031 |
| MABTHERA 100 Injection | H2005/272/16543 | F. HOFFMAN-LA ROCHE LTD | active | 21 Apr 2031 |
| INTAMAB 100 I.V INFUSION Injection | H2019/CTD5926/1130ER | INTAS PHARMACEUTICALS LTD | active | 15 Sept 2030 |
| INTAMAB 500 I.V INFUSION Injection | H2019/CTD5925/1131ER | INTAS PHARMACEUTICALS LTD | active | 15 Sept 2030 |
| Ituxredi Concentrate For Solution For Infusion | H2025/CTD12368/26808 | DR. REDDY’S LABORATORIES LIMITED | active | 6 Mar 2030 |
RITUXIMAB — PPB Registration Details
PPB (Kenya) has 5 registered products containing RITUXIMAB, of which 5 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track RITUXIMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.